CA2478567A1 - A device and method for treatment of external surfaces of a body utilizing a light-emitting container - Google Patents
A device and method for treatment of external surfaces of a body utilizing a light-emitting container Download PDFInfo
- Publication number
- CA2478567A1 CA2478567A1 CA002478567A CA2478567A CA2478567A1 CA 2478567 A1 CA2478567 A1 CA 2478567A1 CA 002478567 A CA002478567 A CA 002478567A CA 2478567 A CA2478567 A CA 2478567A CA 2478567 A1 CA2478567 A1 CA 2478567A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- light emitting
- emitting container
- minutes
- emits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 78
- 238000011282 treatment Methods 0.000 title claims description 78
- 239000000463 material Substances 0.000 claims description 45
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 239000003504 photosensitizing agent Substances 0.000 claims description 14
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 12
- 206010000496 acne Diseases 0.000 claims description 12
- 208000000260 Warts Diseases 0.000 claims description 8
- 210000004209 hair Anatomy 0.000 claims description 8
- 201000010153 skin papilloma Diseases 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 208000017520 skin disease Diseases 0.000 claims description 6
- 239000003860 topical agent Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 claims description 4
- 231100000241 scar Toxicity 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 230000002165 photosensitisation Effects 0.000 claims description 3
- 235000019499 Citrus oil Nutrition 0.000 claims description 2
- 206010051246 Photodermatosis Diseases 0.000 claims description 2
- 239000010500 citrus oil Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000008845 photoaging Effects 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 230000001678 irradiating effect Effects 0.000 claims 6
- 238000001429 visible spectrum Methods 0.000 claims 4
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 23
- 229960002749 aminolevulinic acid Drugs 0.000 description 22
- 230000000694 effects Effects 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 13
- 230000003902 lesion Effects 0.000 description 12
- 230000000699 topical effect Effects 0.000 description 12
- 230000002087 whitening effect Effects 0.000 description 12
- 208000009621 actinic keratosis Diseases 0.000 description 11
- 229960002163 hydrogen peroxide Drugs 0.000 description 11
- -1 polycyclic aromatic compounds Chemical class 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 229950003776 protoporphyrin Drugs 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002428 photodynamic therapy Methods 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 201000004681 Psoriasis Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 239000004065 semiconductor Substances 0.000 description 5
- 206010041823 squamous cell carcinoma Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 210000004919 hair shaft Anatomy 0.000 description 3
- 239000000416 hydrocolloid Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZHBOFZNNPZNWGB-UHFFFAOYSA-N 9,10-bis(phenylethynyl)anthracene Chemical compound C1=CC=CC=C1C#CC(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 ZHBOFZNNPZNWGB-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000005440 Basal Cell Neoplasms Diseases 0.000 description 2
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 208000017572 squamous cell neoplasm Diseases 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- YKSGNOMLAIJTLT-UHFFFAOYSA-N violanthrone Chemical compound C12=C3C4=CC=C2C2=CC=CC=C2C(=O)C1=CC=C3C1=CC=C2C(=O)C3=CC=CC=C3C3=CC=C4C1=C32 YKSGNOMLAIJTLT-UHFFFAOYSA-N 0.000 description 2
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 1
- DCCXNTCSVXAHAN-UHFFFAOYSA-N 1,5-dichloro-9,10-bis(2-phenylethynyl)anthracene Chemical compound C12=C(Cl)C=CC=C2C(C#CC=2C=CC=CC=2)=C2C(Cl)=CC=CC2=C1C#CC1=CC=CC=C1 DCCXNTCSVXAHAN-UHFFFAOYSA-N 0.000 description 1
- DYZYNUQMTZWZAO-UHFFFAOYSA-N 1-(2-phenylethynyl)anthracene Chemical class C1=CC=CC=C1C#CC1=CC=CC2=CC3=CC=CC=C3C=C12 DYZYNUQMTZWZAO-UHFFFAOYSA-N 0.000 description 1
- ISGNKKCVOWFMSF-UHFFFAOYSA-N 1-methoxy-9,10-bis(2-phenylethynyl)anthracene Chemical compound C12=CC=CC=C2C(C#CC=2C=CC=CC=2)=C2C(OC)=CC=CC2=C1C#CC1=CC=CC=C1 ISGNKKCVOWFMSF-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- OUHYGBCAEPBUNA-UHFFFAOYSA-N 5,12-bis(phenylethynyl)naphthacene Chemical class C1=CC=CC=C1C#CC(C1=CC2=CC=CC=C2C=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 OUHYGBCAEPBUNA-UHFFFAOYSA-N 0.000 description 1
- FCNCGHJSNVOIKE-UHFFFAOYSA-N 9,10-diphenylanthracene Chemical class C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 FCNCGHJSNVOIKE-UHFFFAOYSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 235000007070 Angelica archangelica Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 235000021512 Cinnamomum verum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000018035 Dental disease Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000018386 EGF Family of Proteins Human genes 0.000 description 1
- 108010066486 EGF Family of Proteins Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 101001038006 Homo sapiens Lysophosphatidic acid receptor 3 Proteins 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 229910004809 Na2 SO4 Inorganic materials 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229940028420 bactroban Drugs 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000011575 calcium Chemical class 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 229940020485 elidel Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ADRVRLIZHFZKFE-UHFFFAOYSA-N ethanediperoxoic acid Chemical compound OOC(=O)C(=O)OO ADRVRLIZHFZKFE-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229940056319 ferrosoferric oxide Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 229940063190 flagyl Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000007954 growth retardant Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- PREAJQDJMZQQOQ-UHFFFAOYSA-M lithium;2-chlorobenzoate Chemical compound [Li+].[O-]C(=O)C1=CC=CC=C1Cl PREAJQDJMZQQOQ-UHFFFAOYSA-M 0.000 description 1
- PSBOOKLOXQFNPZ-UHFFFAOYSA-M lithium;2-hydroxybenzoate Chemical compound [Li+].OC1=CC=CC=C1C([O-])=O PSBOOKLOXQFNPZ-UHFFFAOYSA-M 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FPTPAIQTXYFGJC-UHFFFAOYSA-N metronidazole hydrochloride Chemical group Cl.CC1=NC=C([N+]([O-])=O)N1CCO FPTPAIQTXYFGJC-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- KASDHRXLYQOAKZ-XDSKOBMDSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-XDSKOBMDSA-N 0.000 description 1
- 239000011591 potassium Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 229940112971 protopic Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000037316 sun-exposed skin Effects 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 230000036367 tooth discoloration Effects 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0606—Mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0656—Chemical light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Surgical Instruments (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36497602P | 2002-03-15 | 2002-03-15 | |
| US60/364,976 | 2002-03-15 | ||
| PCT/US2003/008156 WO2003077996A2 (en) | 2002-03-15 | 2003-03-17 | A device and method for treatment of external surfaces of a body utilizing a light-emitting container |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2478567A1 true CA2478567A1 (en) | 2003-09-25 |
Family
ID=28041996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002478567A Abandoned CA2478567A1 (en) | 2002-03-15 | 2003-03-17 | A device and method for treatment of external surfaces of a body utilizing a light-emitting container |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050080465A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1490150A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005520606A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003222006A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2478567A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003077996A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119705B2 (en) | 1998-06-08 | 2015-09-01 | Thermotek, Inc. | Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis |
| US20050143797A1 (en) | 2003-07-18 | 2005-06-30 | Thermotek, Inc. | Compression sequenced thermal therapy system |
| US7813787B2 (en) * | 2002-07-31 | 2010-10-12 | Inspektor Research Systems Bv | Dental implement and method for tooth surface inspection |
| US7713294B2 (en) | 2002-08-28 | 2010-05-11 | Nomir Medical Technologies, Inc. | Near infrared microbial elimination laser systems (NIMEL) |
| AU2004241087A1 (en) * | 2003-05-16 | 2004-12-02 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
| US7744592B2 (en) * | 2003-05-16 | 2010-06-29 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
| US8128672B2 (en) | 2006-05-09 | 2012-03-06 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
| US8574278B2 (en) | 2006-05-09 | 2013-11-05 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| US20080275532A1 (en) * | 2003-09-12 | 2008-11-06 | Ya-Man Ltd. | Treatment Device |
| GB0324254D0 (en) * | 2003-10-16 | 2003-11-19 | Euphotonics Ltd | Apparatus for illuminating a zone of mammalian skin |
| US20080038685A1 (en) * | 2003-12-15 | 2008-02-14 | Showa Yakuhin Kako Co., Ltd. | Light Irradiation Device For Oral Cavity |
| CA2556402A1 (en) * | 2004-02-13 | 2005-08-25 | Fancl Corporation | Method of chemiluminescence-utilizing makeup and beautification, luminant for skin irradiation beautification and makeup/ beautification equipment |
| US20050256552A1 (en) * | 2004-05-17 | 2005-11-17 | White Robert L | Toenail fungus eradicator |
| US10765785B2 (en) | 2004-07-19 | 2020-09-08 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
| US10016583B2 (en) | 2013-03-11 | 2018-07-10 | Thermotek, Inc. | Wound care and infusion method and system utilizing a thermally-treated therapeutic agent |
| WO2006020602A1 (en) * | 2004-08-09 | 2006-02-23 | Lumiport, Llc | Skin treatment phototherapy device |
| MX2007007623A (es) * | 2004-12-22 | 2007-08-03 | Gillette Co | Reduccion del crecimiento del pelo. |
| US8109981B2 (en) * | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
| US20060173514A1 (en) * | 2005-02-02 | 2006-08-03 | Advanced Photodynamic Technologies, Inc. | Wound treatment device for photodynamic therapy and method of using same |
| US7153131B2 (en) * | 2005-02-07 | 2006-12-26 | Crohn Enterprises Ltd. | Intraoral illumination device |
| US7582067B2 (en) * | 2005-03-15 | 2009-09-01 | Ted Gerard Van Acker | Prepared medication applicator including a swab and a pharmacological active agent |
| US20070036770A1 (en) * | 2005-08-12 | 2007-02-15 | Wagner Darrell O | Biologic device for regulation of gene expression and method therefor |
| TW200722070A (en) * | 2005-12-13 | 2007-06-16 | Health & Welfare Technology Inc | One kind of apparatus for stimulating acupuncture points on the face |
| US8048089B2 (en) | 2005-12-30 | 2011-11-01 | Edge Systems Corporation | Apparatus and methods for treating the skin |
| WO2007106856A2 (en) * | 2006-03-14 | 2007-09-20 | Allux Medical, Inc. | Phototherapy device and method of providing phototherapy to a body surface |
| US9566088B2 (en) | 2006-03-29 | 2017-02-14 | Edge Systems Llc | Devices, systems and methods for treating the skin |
| WO2014151104A1 (en) | 2013-03-15 | 2014-09-25 | Edge Systems Llc | Devices, systems and methods for treating the skin |
| WO2008017975A1 (en) * | 2006-08-07 | 2008-02-14 | Koninklijke Philips Electronics N.V. | System of plaster and radiation device |
| US20080076836A1 (en) * | 2006-09-01 | 2008-03-27 | Cardiac Pacemakers, Inc | Method and apparatus for using light to enhance cell growth and survival |
| JP4769948B2 (ja) * | 2007-03-31 | 2011-09-07 | 国立大学法人山口大学 | 医療用発光装置 |
| US20090012515A1 (en) * | 2007-07-06 | 2009-01-08 | Hoenig Peter A | Devices, systems and methods for treating tissues |
| EP2240099B1 (en) | 2008-01-04 | 2018-02-21 | Edge Systems LLC | Apparatus for treating the skin |
| US20090177253A1 (en) * | 2008-01-08 | 2009-07-09 | Oregon Aesthetic Technologies | Skin therapy system |
| WO2009097451A1 (en) | 2008-01-29 | 2009-08-06 | Edge Systems Corporation | Apparatus and method for treating the skin |
| US8192418B2 (en) * | 2009-03-10 | 2012-06-05 | Medtronic, Inc. | Releasing a material within a medical device via an optical feedthrough |
| US9724784B2 (en) * | 2009-03-10 | 2017-08-08 | Medtronic, Inc. | Optical feedthrough for medical devices |
| US20100234927A1 (en) * | 2009-03-11 | 2010-09-16 | Mei-Chun Lin | Lighting apparatus of facial and lighting method thereof |
| US8399731B2 (en) * | 2009-03-19 | 2013-03-19 | Covidien Lp | Phototherapy wound treatment |
| SG177773A1 (en) * | 2009-07-27 | 2012-03-29 | Cyalume Technologies Inc | Combined thermal and chemiluminescent reaction system |
| TW201143832A (en) * | 2010-06-09 | 2011-12-16 | Forward Electronics Co Ltd | Phototherapy patch |
| WO2012040854A1 (en) * | 2010-09-29 | 2012-04-05 | Yumalite Inc. | Head mounted light therapy device |
| KR101883660B1 (ko) | 2010-10-24 | 2018-07-31 | 사이륨 테크놀로지즈 인코포레이티드 | 복합된 열 및 화학발광 반응 시스템 |
| US20120271219A1 (en) * | 2011-04-19 | 2012-10-25 | David John Weisgerber | Combined Energy and Topical Composition Application For Regulating the Condition of Mammalian Skin |
| US10512587B2 (en) | 2011-07-27 | 2019-12-24 | Thermotek, Inc. | Method and apparatus for scalp thermal treatment |
| EP2550925A1 (en) * | 2011-07-28 | 2013-01-30 | Eduardo Antonio Gomez de Diego | Multipurpose portable laser depilationdevice |
| DK2747693T3 (en) * | 2011-08-26 | 2018-07-02 | On Light Sciences Inc | SYSTEM AND PROCEDURE FOR TATTOO REMOVAL |
| US10195458B2 (en) | 2011-09-08 | 2019-02-05 | Johnson & Johnson Consumer Inc. | Light therapy platform enhanced controller |
| US10092770B2 (en) | 2011-09-08 | 2018-10-09 | Johnson & Johnson Consumer Inc. | Light therapy spot applicator |
| US9789333B2 (en) | 2011-09-08 | 2017-10-17 | Johnson & Johnson Consumer Inc. | Light therapy platform system |
| US10434325B2 (en) | 2011-09-08 | 2019-10-08 | Johnson & Johnson Consumer Inc. | Light therapy platform mobile device applications |
| US10090694B2 (en) | 2011-09-08 | 2018-10-02 | Johnson & Johnson Consumer Inc. | Light therapy platform mobile phone charger |
| US10272257B2 (en) | 2011-09-08 | 2019-04-30 | Johnson & Johnson Consumer, Inc. | Light therapy platform inductive mask and charger |
| US10022554B2 (en) | 2013-03-15 | 2018-07-17 | Johnson & Johnson Consumer Inc. | Light therapy bandage system |
| US10213618B2 (en) | 2011-09-08 | 2019-02-26 | Johnson & Johnson Consumer, Inc. | Light therapy platform combination mask |
| US8771328B2 (en) | 2011-09-08 | 2014-07-08 | La Lumiere Llc | Light therapy platform system |
| TWI670098B (zh) * | 2011-10-14 | 2019-09-01 | 日商日東電工股份有限公司 | 用於創傷癒合之發光裝置、光療系統及發光裝置與光療系統之用途 |
| US20130103123A1 (en) | 2011-10-14 | 2013-04-25 | Sazzadur Rahman Khan | Light-Emitting Devices for Wound Healing |
| US9687669B2 (en) | 2011-11-09 | 2017-06-27 | John Stephan | Wearable light therapy apparatus |
| US10195379B2 (en) | 2012-03-06 | 2019-02-05 | Koninklijke Philips N.V. | Patient interface having illuminated portion |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| WO2013162728A1 (en) | 2012-04-24 | 2013-10-31 | Thermotek, Inc. | Method and system for therapeutic use of ultra-violet light |
| US9168178B2 (en) * | 2012-05-22 | 2015-10-27 | Covidien Lp | Energy-delivery system and method for controlling blood loss from wounds |
| US20140088670A1 (en) * | 2012-09-25 | 2014-03-27 | Ines Verner Rashkovsky | Devices and methods for stimulation of hair growth |
| US10300180B1 (en) | 2013-03-11 | 2019-05-28 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
| US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| CA2999499C (en) | 2013-03-15 | 2020-04-07 | Carewear Corp. | Light and ultrasonic transducer device |
| US10166402B2 (en) | 2013-05-16 | 2019-01-01 | Excelitas Technologies Corp. | Visible light photo-disinfection patch |
| WO2015000058A1 (en) | 2013-07-03 | 2015-01-08 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| EP3068481B1 (en) | 2013-11-11 | 2020-01-01 | Thermotek, Inc. | System for wound care |
| DE202013105127U1 (de) * | 2013-11-13 | 2015-02-18 | Swiss Red Ag | Raum und Lichtdeckensystem zur Durchführung der Photodynamischen Therapie |
| JP2017509433A (ja) * | 2014-04-01 | 2017-04-06 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 組織充填剤組成物および使用方法 |
| AU2015266676A1 (en) | 2014-05-29 | 2016-12-15 | New Skin Therapies, LLC, d/b/a/ NST Consulting, LLC | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
| US11358002B2 (en) | 2014-05-29 | 2022-06-14 | Raymond R. Blanche | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
| WO2016069700A1 (en) | 2014-10-28 | 2016-05-06 | Sensor Electronic Technology, Inc. | Adhesive device with ultraviolet element |
| US10179229B2 (en) | 2014-12-23 | 2019-01-15 | Edge Systems Llc | Devices and methods for treating the skin using a porous member |
| EP3795204B1 (en) | 2014-12-23 | 2023-10-25 | HydraFacial LLC | Device for treating the skin using a rollerball |
| TW201613750A (en) * | 2015-08-13 | 2016-04-16 | Zheng-Hong Shi | Pulsed color light dressing film product |
| US10646319B2 (en) * | 2015-12-30 | 2020-05-12 | Colgate-Palmolive Company | Thin, flexible powered oral care device |
| US10765885B2 (en) * | 2016-02-26 | 2020-09-08 | Nanoco Technologies Ltd. | Phototherapy mask with quantum dot phosphors |
| CN109475285B (zh) | 2016-04-13 | 2021-07-06 | 检查员研究系统公司 | 双频牙齿检查 |
| PL3448529T3 (pl) * | 2016-04-26 | 2024-04-02 | Peace Out Inc. | Leczniczy opatrunek hydrokoloidowy do leczenia trądziku |
| AU2017271535B2 (en) | 2016-05-26 | 2022-09-08 | Carewear Corp | Photoeradication of microorganisms with pulsed purple or blue light |
| WO2018022775A1 (en) * | 2016-07-27 | 2018-02-01 | Zhang Jack K | Componentry and devices for light therapy delivery and methods related thereto |
| US20190083809A1 (en) | 2016-07-27 | 2019-03-21 | Z2020, Llc | Componentry and devices for light therapy delivery and methods related thereto |
| US10912739B2 (en) | 2017-10-16 | 2021-02-09 | Peace Out Inc. | Hydrocolloid-based skin treatment |
| US11020605B2 (en) | 2018-05-29 | 2021-06-01 | Carewear Corp. | Method and system for irradiating tissue with pulsed blue and red light to reduce muscle fatigue, enhance wound healing and tissue repair, and reduce pain |
| KR102783037B1 (ko) * | 2019-05-16 | 2025-03-19 | 주식회사 엘지생활건강 | 얼굴 미용기기 및 마스크 시트 |
| AU2020303417B2 (en) * | 2019-06-25 | 2025-08-28 | Sun Pharmaceutical Industries, Inc. | Methods for reducing pain during photodynamic therapy of actinic keratosis |
| US11291474B2 (en) | 2020-01-06 | 2022-04-05 | Ed F. Nicolas | Skin treatment tool applicator tip |
| WO2023039524A1 (en) | 2021-09-10 | 2023-03-16 | Hydrafacial Llc | Devices, systems and methods for treating the skin |
| USD1016615S1 (en) | 2021-09-10 | 2024-03-05 | Hydrafacial Llc | Container for a skin treatment device |
| USD1065551S1 (en) | 2021-09-10 | 2025-03-04 | Hydrafacial Llc | Skin treatment device |
| USD1116120S1 (en) | 2021-10-11 | 2026-03-03 | Hydrafacial Llc | Skin treatment device |
| USD1042807S1 (en) | 2021-10-11 | 2024-09-17 | Hydrafacial Llc | Skin treatment tip |
| US11684586B1 (en) | 2022-02-28 | 2023-06-27 | Peace Out, Llc | Anhydrous hydrocolloid matrix comprising homogeneously distributed encapsulated therapeutic agents |
| USD1112778S1 (en) | 2022-03-04 | 2026-02-10 | Hydrafacial Llc | Light therapy device for skin care |
| USD1084369S1 (en) | 2023-02-10 | 2025-07-15 | Hydrafacial Llc | Skin treatment tip |
| USD1052743S1 (en) | 2024-04-27 | 2024-11-26 | Goddess's Messenger Ltd | Led light therapy mask |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL152290B (nl) | 1965-09-08 | 1977-02-15 | American Cyanamid Co | Werkwijze ter bereiding van chemiluminescerende mengsels. |
| DE2029899A1 (de) | 1970-06-18 | 1971-12-30 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Verfahren zum Vernetzen von Füllstoffen enthaltendem natürlichem und synthetischem Kautschuk bzw. diese enthaltenden Mischungen |
| US3691085A (en) | 1970-07-13 | 1972-09-12 | American Cyanamid Co | Method of controlling the lifetime of oxalate ester chemiluminescent reactions |
| US3704231A (en) | 1971-02-16 | 1972-11-28 | American Cyanamid Co | Chemiluminescent additives |
| RU2145247C1 (ru) * | 1998-04-10 | 2000-02-10 | Жаров Владимир Павлович | Фотоматричное терапевтическое устройство для лечения протяженных патологий |
| US6267914B1 (en) | 1999-11-02 | 2001-07-31 | Omniglow Corporation | Variable chemiluminescent process and product |
-
2003
- 2003-03-17 AU AU2003222006A patent/AU2003222006A1/en not_active Abandoned
- 2003-03-17 CA CA002478567A patent/CA2478567A1/en not_active Abandoned
- 2003-03-17 EP EP03717989A patent/EP1490150A1/en not_active Withdrawn
- 2003-03-17 WO PCT/US2003/008156 patent/WO2003077996A2/en not_active Ceased
- 2003-03-17 JP JP2003576047A patent/JP2005520606A/ja not_active Withdrawn
-
2004
- 2004-09-14 US US10/941,043 patent/US20050080465A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1490150A1 (en) | 2004-12-29 |
| JP2005520606A (ja) | 2005-07-14 |
| WO2003077996A2 (en) | 2003-09-25 |
| AU2003222006A1 (en) | 2003-09-29 |
| US20050080465A1 (en) | 2005-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050080465A1 (en) | Device and method for treatment of external surfaces of a body utilizing a light-emitting container | |
| CA2452408C (en) | Method and apparatus for the photomodulation of living cells | |
| KR101239925B1 (ko) | 모발 성장 촉진을 위한 방법 및 장치 | |
| US6676655B2 (en) | Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen | |
| US8454991B2 (en) | Method and device for photodynamic therapy | |
| US20040225339A1 (en) | Light treatments for acne and other disorders of follicles | |
| US20100174222A1 (en) | Method and apparatus for acne treatment using low intensity light therapy | |
| JP6595484B2 (ja) | 光損傷皮膚のパルス光力学的処置 | |
| AU2002320215A1 (en) | Method and apparatus for the photomodulation of living cells | |
| KR20070054639A (ko) | 광 및 유효제를 사용한 피부 처치방법 | |
| WO2007092349A2 (en) | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders | |
| ES2293334T3 (es) | Aparato para iluminar una zona de piel de mamifero. | |
| Gu et al. | Light-emitting diodes for healthcare and well-being | |
| Yu | Photodynamic therapy: the light treatment for cutaneous non-melanoma malignancies | |
| Goldberg | Laser acne treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |